Microsoft Word - ITOC1_Final_programme - Oncolytic virus - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-09-09 08:02:55 Cancer immunotherapy Cancer vaccine Cancer immunology Renal cell carcinoma Immune system Oncolytic virus Interleukin Melanoma Active immunotherapy Medicine Immunology Immunotherapy		Microsoft Word - ITOC1_Final_programme Add to Reading List Source URL: itoc-conference.eu Download Document from Source Website File Size: 131,69 KB Share Document on Facebook

	The UNM Interdisciplinary HPV Prevention Center DocID: 1rtWC - View Document
	VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01 Basel (Switzerland) and Mannheim (Germany), July 12, 2016 – VAXIMM AG, a Swiss/German biotech company focused on develo DocID: 1rgZo - View Document
	Cover Conference-at-a-Glance Final Agenda Eighth Annual DocID: 1rglJ - View Document
	Anticancer ResJan;33(1):Intratumoural interleukin-2 therapy can induce regression of nonresectable mastocytoma in dogs. Ziekman PG1, Otter WD, Tan JF, Teske E, Kirpensteijn J, Koten JW, Jacobs JJ. Author DocID: 1r4NE - View Document
	Press release Clinical Phase I Results of GANYMED’s iMAB362 Antibody Demonstrate Excellent Safety Mainz, Germany, August 04, A clinical first-in-human Phase I multi center study with GANYMED’s monoclonal anti DocID: 1r3p4 - View Document